Senate Bill Would Streamline FDA's New Device Reviews

Law360, New York (February 3, 2012, 3:27 PM EST) -- Two lawmakers on the U.S. Senate's top health committee introduced legislation Thursday that they said would dramatically shorten the U.S. Food and Drug Administration’s approval process for innovative medical devices.

Sens. Bob Casey, D-Pa., and John McCain, R-Ariz., said their bill would streamline the regulatory review process for brand-new medical devices that aren't similar to any existing devices.

Under the Safe, Efficient and Transparent Medical Device Approval Act, manufacturers with such new devices would be able to skip the 510(k) process, which the senators said was...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.